Skip to main content
AIKO logo

Alternative Investment Corporation (AIKO) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.9833 $0.00 (0.00%)
MCap: $15.3M| Vol: 100|

Market cap $15.3M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Alternative Investment Corporation (AIKO) trades at $0.9833. Alternative Investment Corporation (AIKO) is a shell company focused on real estate and biotech investment opportunities. Market cap: $15.3M, Sector: Financials.

Price as of · Last analyzed: Mar 17, 2026
Alternative Investment Corporation (AIKO) is a shell company focused on real estate and biotech investment opportunities. The company, founded in 2007, operates with minimal activity and a small team.

Analyst Coverage for AIKO: AIKO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • ASPC · A SPAC III Acquisition Corp. · 43 /100
  • BKHA · Black Hawk Acquisition Corporation · 47 /100
  • AFJK · Aimei Health Technology Co., Ltd · 43 /100

See all scored stocks →

Alternative Investment Corporation (AIKO) Financial Services Profile

CEOAntonio Treminio
Employees2
HeadquartersNew York City, US
IPO Year2009

Alternative Investment Corporation (AIKO) is a shell company exploring investment opportunities in distressed real estate and biotech. With a small team and limited operations, AIKO seeks to capitalize on alternative real estate developments and emerging technologies, operating within the financial services sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for AIKO?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Alternative Investment Corporation (AIKO) presents a speculative investment opportunity, primarily driven by its potential to identify and capitalize on distressed real estate and biotech ventures. With a market capitalization of $15.3M and a negative P/E ratio of -4438.17, AIKO's valuation is highly sensitive to future investment outcomes. The company's success depends on its ability to secure and manage profitable investments. Key catalysts include successful acquisitions or partnerships in the real estate or biotech sectors. However, the company's lack of significant operations and high beta of -188.66 indicate substantial risk. Investors should carefully consider the speculative nature of AIKO's business model and the potential for significant volatility.

Based on FMP financials and quantitative analysis

AIKO Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $15.3M reflects the company's limited operational activity and speculative nature.

  • Negative P/E ratio of -4438.17 indicates a lack of profitability and reliance on future investment outcomes.
  • High beta of -188.66 suggests extreme volatility and sensitivity to market fluctuations.
  • Focus on distressed real estate and biotech sectors presents both high-risk and high-reward investment potential.
  • Small team of two employees indicates a lean operational structure and reliance on external partnerships.

Who Are AIKO's Competitors?

AIKO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
IHAI Innovative Holdings Alliance, Inc. $0.09 +12.88% $5.98M —
ASPC A SPAC III Acquisition Corp. $10.20 -0.20% $23.8M 43 5-pillar
BKHA Black Hawk Acquisition Corporation $6.48 -24.74% $26.9M 47 5-pillar
AFJK Aimei Health Technology Co., Ltd $11.90 +0.76% $37.7M 43 5-pillar
AIB AIB Acquisition Corporation $0.63 -3.82% $48.5M 30 5-pillar
PGAC Pantages Capital Acquisition Corporation $10.87 -0.09% $55.8M 55 5-pillar
CHAR Charlton Aria Acquisition Corporation $10.99 +0.32% $57.6M 46 5-pillar
BPAC Bullpen Parlay Acquisition Company $10.31 +0.19% $76.1M 51 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AIKO's Key Strengths?

Flexibility to invest in diverse sectors.

  • Small team allows for quick decision-making.
  • Focus on high-growth potential sectors (real estate, biotech).
  • Low operational overhead.

What Are AIKO's Weaknesses?

Limited operating history.

  • Small team size may limit execution capabilities.
  • Reliance on external partnerships.
  • Lack of significant revenue generation.

What Could Drive AIKO Stock Higher?

Potential acquisition of distressed real estate assets.

  • Possible investment in a promising biotech startup.
  • Exploration of strategic partnerships with established firms.
  • Evaluation of new geographic markets for expansion.
  • Adoption of fintech solutions to improve efficiency.

What Are the Key Risks for AIKO?

Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.

  • Market volatility in the real estate and biotech sectors.
  • Competition from other investment firms.
  • Regulatory changes impacting target sectors.
  • Economic downturn affecting investment valuations.
  • Limited financial disclosure increases investment risk.

What Are the Growth Opportunities for AIKO?

  • Expansion into Distressed Real Estate: AIKO can capitalize on the distressed real estate market by acquiring undervalued properties and implementing turnaround strategies. The distressed real estate market is estimated to be worth billions of dollars, offering significant potential for growth. This opportunity requires AIKO to develop expertise in property valuation, renovation, and management. Timeline: Ongoing.
  • Investment in Biotech Startups: AIKO can invest in early-stage biotech companies with promising technologies and high growth potential. The biotech industry is experiencing rapid innovation and attracts substantial venture capital funding. This strategy requires AIKO to develop expertise in scientific evaluation, regulatory compliance, and intellectual property management. Timeline: Ongoing.
  • Strategic Partnerships: AIKO can form strategic partnerships with established real estate developers or biotech firms to leverage their expertise and resources. Partnerships can provide access to deal flow, technical expertise, and capital. Successful partnerships can accelerate AIKO's growth and reduce its risk profile. Timeline: Ongoing.
  • Geographic Expansion: AIKO can expand its investment focus to new geographic markets with attractive real estate or biotech opportunities. Geographic expansion can diversify AIKO's portfolio and reduce its reliance on specific regions. This strategy requires AIKO to conduct thorough market research and establish local networks. Timeline: Ongoing.
  • Adoption of Fintech Solutions: AIKO can adopt fintech solutions to improve its investment decision-making and operational efficiency. Fintech tools can provide access to real-time market data, automated valuation models, and streamlined transaction processes. The adoption of fintech can enhance AIKO's competitiveness and improve its financial performance. Timeline: Ongoing.

What Are AIKO's Competitive Advantages?

  • Access to capital for investment opportunities.
  • Network of contacts within the real estate and biotech industries.
  • Expertise in identifying and evaluating undervalued assets.
  • Flexibility to invest in a wide range of opportunities.

What Does AIKO Do?

Alternative Investment Corporation, formerly known as Paradigm Resource Management Corporation, was established in 2007 and rebranded in September 2015. Headquartered in New York City, the company currently maintains a small team of two employees. AIKO's business model centers around identifying and pursuing investment opportunities, primarily within the real estate sector. The company's focus includes distressed real estate assets and alternative real estate developments. Additionally, AIKO explores investment possibilities within the biotech sector, targeting emerging technologies. However, it is crucial to note that Alternative Investment Corporation does not have significant ongoing operations. Its activities are centered on the evaluation and potential acquisition of assets rather than active management or development. The company's success hinges on its ability to identify and secure promising investment opportunities in its target sectors. AIKO's limited operational footprint and small team size suggest a reliance on external partnerships or acquisitions to execute its investment strategy. The company's strategic direction and financial performance are closely tied to the real estate and biotech markets, exposing it to sector-specific risks and opportunities.

What Products and Services Does AIKO Offer?

  • Identifies investment opportunities in the real estate sector.
  • Focuses on distressed real estate assets.
  • Explores alternative real estate developments.
  • Evaluates investment opportunities in the biotech sector.
  • Targets emerging technologies in biotech.
  • Seeks to acquire undervalued assets.
  • Manages a small team to oversee investment activities.

How Does AIKO Make Money?

  • Identifies and evaluates potential investment opportunities in real estate and biotech.
  • Acquires or partners with companies or assets that align with its investment strategy.
  • Aims to generate returns through the appreciation of asset values or the successful development of new technologies.

What Industry Does AIKO Operate In?

Alternative Investment Corporation operates within the shell company segment of the financial services sector. Shell companies are often characterized by minimal operations and a focus on identifying and acquiring investment opportunities. The competitive landscape includes other shell companies seeking to capitalize on undervalued assets or emerging technologies. The success of these companies depends on their ability to identify and secure profitable investments. The real estate and biotech sectors, which are AIKO's primary areas of focus, are subject to market cycles and regulatory changes, impacting the company's investment prospects.

Who Are AIKO's Key Customers?

  • Not applicable, as AIKO is primarily an investment vehicle rather than a provider of goods or services.
  • Potential portfolio companies in the real estate and biotech sectors.
  • Investors seeking exposure to alternative investment opportunities.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Alternative Investment Corporation operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York, United States.

Alternative Investment Corporation (AIKO) Valuation Context

Valued at $15.3M, AIKO is classified as a micro-cap stock.

ROE 0%

Key Financial Metrics

Return on equity for Alternative Investment Corporation stands at 0.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -27.9%, showing how much profit it generates from its asset base. Its free cash flow yield is -0.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 1/9

Financial Health

Alternative Investment Corporation's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

AIKO Financials

Bull Case vs Bear Case

Bull Case

  • Flexibility to invest in diverse sectors.
  • Small team allows for quick decision-making.
  • Focus on high-growth potential sectors (real estate, biotech).
  • Low operational overhead.

Bear Case

  • Limited operating history.
  • Small team size may limit execution capabilities.
  • Reliance on external partnerships.
  • Lack of significant revenue generation.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

AIKO Latest News

No recent news available for AIKO.

AIKO Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AIKO.

Price Targets

Wall Street price target analysis for AIKO.

AIKO MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AIKO; grades run from A+ (80-100) to F (below 30).

Leadership: Antonio Treminio

Managing

Antonio Treminio currently manages Alternative Investment Corporation, overseeing a small team of two employees. His leadership is focused on guiding the company's investment strategy in the real estate and biotech sectors.

Track Record: Due to the limited operational activity and lack of publicly available information, it is difficult to assess Antonio Treminio's track record at Alternative Investment Corporation. Key milestones and strategic decisions under his leadership are not readily apparent.

AIKO OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, encompassing companies that may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available and may be subject to greater risks. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. These companies are not required to adhere to the same reporting standards as those listed on major exchanges like the NYSE or NASDAQ.

  • OTC Tier: OTC Other
Liquidity: Liquidity in OTC Other stocks is typically very low, with wide bid-ask spreads and limited trading volume. This can make it difficult to buy or sell shares without significantly impacting the price. Investors may experience challenges in executing large trades or exiting their positions quickly. The lack of liquidity increases the risk of price manipulation and volatility.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in AIKO.
  • Low trading volume and wide bid-ask spreads can lead to price volatility.
  • OTC Other stocks are subject to less regulatory oversight, increasing the risk of fraud or manipulation.
  • The company's lack of significant operations adds to the uncertainty surrounding its future prospects.
  • Negative P/E ratio and low market capitalization indicate financial instability.
Due Diligence Checklist:
  • Verify the company's registration and legal standing.
  • Review any available financial statements and disclosures.
  • Assess the company's business plan and investment strategy.
  • Research the background and experience of the company's management team.
  • Understand the risks associated with investing in OTC Other stocks.
  • Monitor trading volume and price activity for signs of manipulation.
  • Consult with a financial advisor before making any investment decisions.
Legitimacy Signals:
  • Company was founded in 2007.
  • Company is based in New York City.
  • Company changed its name in 2015, suggesting some level of corporate activity.

Common Questions About AIKO (Financials)

Is AIKO a good stock to buy?

Stock Expert AI does not rate AIKO buy, sell or hold. Alternative Investment Corporation has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the AIKO stock price today?

The last price recorded on this page for Alternative Investment Corporation (AIKO) is $0.9833, as of the Nov 19, 2026 trading session. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What do analysts say about AIKO stock?

As of March 17, 2026, there is no available analyst coverage for Alternative Investment Corporation (AIKO). The company's low market capitalization of $15.3M and limited operational activity likely contribute to the lack of analyst interest. Key valuation metrics, such as the negative P/E ratio of -4438.17, reflect the company's current lack of profitability.

What are the key factors to evaluate for AIKO?

Evaluate AIKO on fundamentals, analyst consensus, and risk factors. The company's success depends on its ability to secure and manage profitable investments. Not financial advice.

How frequently does AIKO data refresh on this page?

AIKO's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven AIKO's recent stock price performance?

Alternative Investment Corporation (AIKO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Flexibility to invest in diverse sectors. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AIKO overvalued or undervalued right now?

Alternative Investment Corporation (AIKO) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research AIKO before investing?

Before investing in Alternative Investment Corporation (AIKO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on the company's operations and financial performance.
  • OTC Other stocks carry significant risks due to the lack of regulatory oversight.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

Stock Deep Dives